Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year
S. Hescot(Institut Curie), Éric Baudin(Institut Gustave Roussy), Jérôme Bertherat(Centre National de la Recherche Scientifique), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), C. Chougnet(Université Paris-Sud), Xavier Bertagna, la Fouchardiere Christelle de, Martin Schlumberger(Université Paris-Saclay), Jean-Louis Wémeau(Université de Lille), Rossella Libé(Hôpital Cochin), Antoine Tabarin(Université de Bordeaux), Françoise Borson‐Chazot(Hospices Civils de Lyon), Isabelle Borget(Inserm), Jenean A. Young, Laurence Amar(Unit of Functional and Adaptive Biology), Sophie Leboulleux(Geneva College), Patricia Niccoli(Institut Paoli-Calmettes), Cao Cui, I. Raingeard(Centre Hospitalier Universitaire de Montpellier), P.-F. Plouin(Université Paris Cité), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5)
15th International & 14th European Congress of Endocrinology
May 1, 2012
Cited by 0
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
|Neuroendocrinology|2012|869
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791